ABC | Volume 114, Nº4, April 2020

Short Editorial Timóteo GRACE score and NT-proBNP Arq Bras Cardiol. 2020; 114(4):673-674 References This is an open-access article distributed under the terms of the Creative Commons Attribution License 1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200. 2. Poole-Wilson PA. Who are the enemies? Lack of oxygen. Eur Heart J Suppl. 2002;4(Suppl G):G15-9. 3. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin 2 and diastolic fiber length. Circulation. 2000;102(25):3074-9. 4. Goetz JP, Christofferson C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increase cardiac BNP expression associated with myocardial ischemia. FASEB J. 2003;17(9):1105-7. 5. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993;88(1):82-91. 6. KwanG, IsaksomSR, Beede J, Clopton P, Maisel AS, Fitzgerald RL. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. J Am Coll Cardiol. 2007;49(11):1186-92. 7. TimóteoAT, Toste A, Ramos R, Miranda F, FerreiraML, Oliveira JA, et al.Does admissionNT-proBNP increasestheprognosticaccuracyofGRACEriskscore in the prediction of short-term mortality after acute coronary syndromes? Acute Card Care. 2009;11(4):236-42. 8. Taiwar S, Squire IB, Downie PF, Mccullough AM, Campton MC, Davies JE, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J. 2000;21(18):1514-21. 9. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, et al. N-terminal-pro brain natriuretic peptide on admission has prognostic value across the whole spectrumof acute coronary syndromes. Circulation. 2004;110(2):128-34. 10. Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina / non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol. 2003;41(8):1264-72. 11. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, CannonCP, et al. Predictors of hospital mortality with global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-53. 12. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for themanagement of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267-315. 13. Souza TMB, Cerqueira Jr AMS, Suerdieck JG, SáNC, SodréGS, Correia VCA, et al. Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary Syndromes. Arq Bras Cardiol. 2020; 114(4):666-672. 674